Skip to content
Stylized image of a human eye.

Millions of People Suffer from Sight-Threatening Corneal Endothelial Diseases

Our Cell Therapy Has the Potential to
Restore Their Vision

Prix Galien USA award logo

Company recognized for innovations in clinically validated cell therapy for corneal endothelial dystrophies

Learn More

Frontal group shot of the Aurion team

Get to know us.

We are a clinical-stage biotech company. We aim to restore vision to all who need it by developing a platform of innovative, accessible, and effective advanced therapies. Our first candidate is a patented cell therapy treatment for corneal endothelial disease.

Latest News